@the_news_21
After US FDA disapproved the emergency use of Bharat Biotech’s Covid-19 vaccine Covaxin Health Ministry during a regular press briefing said it respects the decision saying ‘every country’s regulatory system might have some things in common with others and some things different.”
Dr VK Paul, Member-Health, Niti Aayog said, “Every country’s regulatory system might have some things in common with others & some things different. We respect it. Scientific framework is same but its nuancing is as per context”
He said, “All of these are scientific considerations & keeping those in mind, the nuancing might be different, especially in those countries where science is strong”. “Our manufacturing is strong. They have decided this, we respect it”, he added.
“It’s their decision, should be respected. Our regulator has endorsed licensure for this vaccine & there’s no impact on use of Covaxin in our national program”, he concluded.
